Search


Modality profile: Radiotherapies at #ASCO23 with Dr. Phil Kantoff
Convergent Therapeutics CEO Phil Kantoff describes the use of targeted radiotherapies against cancer. #ASCO23
Jun 4, 2023
Also look for unique social pages for BiotechTV U.
Allucent Clinical Research Organization™ is on a mission to help bring new therapies to light by solving the distinct challenges of small and mid-sized biotech companies. We’re a global provider of comprehensive drug development solutions, including consulting, clinical operations, biometrics, and clinical pharmacology across a variety of therapeutic areas.